BioScience Managers
As an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare, we have a team with the ambition and experience to deliver impressive investment returns.
Latest news
- Adherium announces production & market release of new, next-gen sensors 14 November 2023
- Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus 2 October 2023
- Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus 28 September 2023